NCT03628677 2025-02-04
A Study to Evaluate the Safety and Tolerability of AB154 in Participants With Advanced Malignancies
Arcus Biosciences, Inc.
Phase 1 Completed
Clinical Trials
3 trialsNCT04087018 2024-09-19
Study to Evaluate Safety and Clinical Activity of AB122 in Biomarker Selected Participants With Advanced Solid Tumors
Arcus Biosciences, Inc.
Phase 1 Completed
NCT03713905 2023-04-10
Study of Recombinant Human Anti-PD-1 Monoclonal Antibody for Patients With Advanced Solid Tumors
Guangzhou Gloria Biosciences Co., Ltd.
Phase 1 Completed